Showing 1 - 10 results of 10 for search 'O. V. Margolin', query time: 0.04s
Refine Results
-
1
Experience with outpatient treatment for thromboses and thrombophilias by S A Vasil'ev, V L Vinogradov, É G Gemdzhian, E B Orel, A A Shevelev, O V Margolin
Published 2013-12-01
Article -
2
-
3
CNS involvement and the feasibility of intratecal chemotherapy administration in patients with a nodal form of diffuse large B-cell lymphoma not otherwise specified. Data of prospe... by A U Magomedova, A E Misyurina, J K Mangasarova, L G Gorenkova, O V Margolin, E A Fastova, S K Kravchenko
Published 2019-07-01
Article -
4
Clinical features and diagnosis of Ph - negative myeloproliferative neoplasms occurring in conjunction with the antiphospholipid syndrome by A L Melikyan, I N Subortseva, E A Koloshejnova, E A Gilyazitdinova, K S Shashkina, L A Gorgidze, Zh V Tratsevskaya, O V Margolin
Published 2019-07-01
Article -
5
-
6
-
7
Tuberculosis in patients with lymphoproliferative diseases by L S Al'-Radi, T N Moiseeva, N G Chernova, N N Sharkunov, O V Margolin, I V Shitareva, E A Bariakh, G A Kliasova, L S Roshchina, I É Kostina, S K Kravchenko, A V Pivnik, A I Vorob'ev
Published 2014-11-01
Article -
8
P101: Combination of immune checkpoint inhibitors with BeGEV in the treatment of patients with relapsed and refractory classical Hodgkin’s lymphoma. by Ya.K. Mangasarova, T.N. Moiseeva, L.S. Al-Radi, O.V. Margolin, L.G. Gorenkova, E.S. Nesterova, M.O. Bagova, E.A. Fastova, R.R. Abdurashidova, Z.T. Sarakaeva, Elena Dorokhina, S.K. Kravchenko, A.U. Magomedova, E.E. Zvonkov
Published 2022-10-01
Article -
9
Comparative assessment of efficacy and toxicity of R-DA-EPOCH and R-mNHL-BFM-90 induction courses in the treatment of patients with diffuse large B-cell lymphoma with poor prognost... by M. O. Bagova, A. U. Magomedova, S. K. Kravchenko, Ya. K. Mangasarova, O. V. Margolin, E. S. Nesterova, L. G. Gorenkova, A. E. Misyurina, E. A. Fastova, F. E. Babaeva, K. A. Sychevskaya, S. M. Kulikov, Yu. A. Chabaeva, V. G. Savchenko
Published 2021-09-01
Article -
10
Follicular lymphoma: results of multicenter study of first-line therapy with bendamustine and rituximab, risk factors for adverse events (fl-rus-2013 protocol) by E. S. Nesterova, S. K. Kravchenko, A. M. Kovrigina, E. G. Gemdzhian, L. V. Plastinina, Ya. K. Mangasarova, F. E. Babaeva, A. E. Misyurina, O. V. Margolin, A. U. Magomedova, V. I. Vorobiev, D. S. Maryin, E. A. Baryakh, Yu. Yu. Polyakov, P. A. Zeynalova, E. M. Volodicheva, N. N. Glonina, N. V. Minaeva, G. A. Davydova, V. G. Savchenko
Published 2018-10-01
Article